IP Library › Granted Patent US 11,857,701
Granted Patent B2
US 11,857,701 · App. 18/321,238 · Granted Jan 2, 2024

Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

Inventors: Sarah Mayes (Austin, TX); Christine E. Schmidt (Gainesville, FL)
Assignee: Board Of Regents, The University Of Texas System
A61L31/041A61K31/192A61K31/195A61L31/145A61L31/148A61L31/16A61L2300/414A61L2300/43A61L2300/62
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,857,701
App. No.
18/321,238
Granted
Jan 2, 2024
Kind
B2
Abstract

A non-synthetic, hydrophilic, biodegradable, biocompatible polysaccharide based non-toxic anti-adhesion hydrogel barrier is disclosed herein. The barrier of the present invention is formed by constructing a unique interpenetrating, crosslinked network with a unique porosity. Furthermore, the barrier of the present invention is comprised of tunable biopolymers for controllable mechanical robustness and degradation. The barrier of the present invention effectively reduces unwanted adhesions using non-synthetic components.

Claims (24)

1. An apparatus comprising:

a nerve wrap comprising first and second layers;

wherein the first layer includes a desiccated, translucent, amorphous hydrogel film, the hydrogel film comprising hyaluronic acid and alginate;

wherein the second layer includes collagen;

wherein (a) the first layer is fused to the second layer, (b) the first layer has at least 1% hyaluronic acid by dry weight; and (c) the first layer is anti-adhesive and non-attractive to cells and the second layer is adhesive to cells.

2. The apparatus of claim 1 , wherein the hyaluronic acid is uncrosslinked.

3. The apparatus of claim 2 , wherein the first layer includes no more than 33% hyaluronic acid by dry weight.

4. The apparatus of claim 2 , wherein the first layer is non-cytotoxic.

5. The apparatus of claim 1 , wherein the first layer is negatively charged and hydrophilic.

6. The apparatus of claim 5 , wherein the alginate in the first layer is cross-linked.

7. The apparatus of claim 6 , wherein the alginate includes calcium alginate.

8. The apparatus of claim 5 , wherein the alginate includes sodium alginate.

9. The apparatus of claim 8 , wherein the hydrogel film consists essentially of the hyaluronic acid and the alginate.

10. The apparatus of claim 9 , wherein the first and second layers are both flat and planar.

11. The apparatus of claim 5 , wherein the first and second layers are both flat and planar.

12. The apparatus of claim 11 , wherein the hydrogel film is flat and includes a width, a length, and a thickness that is less than the width and the length.

13. The apparatus of claim 12 , wherein the first layer does not include calcium.

14. The apparatus of claim 12 , wherein the hydrogel film consists essentially of the hyaluronic acid and the alginate.

15. The apparatus of claim 14 , wherein the hydrogel film includes an anionic polymer.

16. The apparatus of claim 14 , wherein the hydrogel film is unpatterned.

17. The apparatus of claim 14 , wherein the hydrogel film is non-synthetic.

18. The apparatus of claim 14 , wherein the first layer is not cross-linked.

19. The apparatus of claim 14 , wherein the hydrogel film is a cast film.

20. The apparatus of claim 14 , wherein the first layer has bioabsorbability the degree of which is based on a ratio of the hyaluronic acid to the alginate.

Continuity (7)
Continuation 17369067 · Jul 7, 2021
Continuation 16400259 · May 1, 2019
Continuation 15596685 · May 16, 2017
Continuation 14803258 · Jul 20, 2015
Continuation 13269344 · Oct 7, 2011
Provisional Application 61391299 · Oct 8, 2010
Related Publication 20230355846A1 · Nov 9, 2023
Cited By (1)
US 12,697,419